Get started
000

NEOPHARM CO., LTD.

No trades
See on Supercharts
Overview
Financials Discussions Technicals Seasonals

092730 chart


Full chart

Key stats


Market capitalization
‪181.13 B‬ KRW
Dividend yield (indicated)
3.24%
Price to earnings Ratio (TTM)
10
Basic EPS (TTM)
1,430 KRW
Net income (FY)
‪23.21 B‬ KRW
Revenue (FY)
‪97.10 B‬ KRW
Shares float
‪8.52 M‬
Beta (1Y)
0.48

Employees


Employees (FY)
153
Revenue / Employee (1Y)
‪487.43 K‬ KRW
Net income / Employee (1Y)
‪116.52 K‬ KRW

About NEOPHARM CO., LTD.


Sector
Consumer Non-Durables
Industry
Household/Personal Care
CEO
Yang-Soo Kim
Website
neopharm.co.kr
Headquarters
Daejeon
Founded
2000
ISIN
KR7092730001
FIGI
BBG000QLSRQ6
NeoPharm Co., Ltd. engages in the development, manufacture, and sale of cosmetics, medical, and health products. Its products include emulsified and functional skin care products for sensitive and dry skin, treatment of atopic dermatitis and psoriasis, and therapy for steroid side effects. The company was founded on July 1, 2000 and is headquartered in Daejeon, South Korea.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

Technicals

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of 092730 is 11,580 KRW — it has decreased by −2.20% in the past 24 hours. Watch NEOPHARM CO., LTD. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange NEOPHARM CO., LTD. stocks are traded under the ticker 092730.
092730 stock has fallen by −11.74% compared to the previous week, the month change is a −10.92% fall, over the last year NEOPHARM CO., LTD. has showed a −0.39% decrease.
092730 reached its all-time high on Apr 11, 2018 with the price of 31,650 KRW, and its all-time low was 1,090 KRW and was reached on Oct 23, 2008. View more price dynamics on 092730 chart.
See other stocks reaching their highest and lowest prices.
092730 stock is 5.55% volatile and has beta coefficient of 0.48. Track NEOPHARM CO., LTD. stock price on the chart and check out the list of the most volatile stocks — is NEOPHARM CO., LTD. there?
Today NEOPHARM CO., LTD. has the market capitalization of ‪176.65 B‬, it has decreased by −9.41% over the last week.
Yes, you can track NEOPHARM CO., LTD. financials in yearly and quarterly reports right on TradingView.
092730 net income for the last quarter is ‪4.34 B‬ KRW, while the quarter before that showed ‪5.88 B‬ KRW of net income which accounts for −26.30% change. Track more NEOPHARM CO., LTD. financial stats to get the full picture.
Yes, 092730 dividends are paid annually. The last dividend per share was 750.00 KRW. As of today, Dividend Yield (TTM)% is 3.24%. Tracking NEOPHARM CO., LTD. dividends might help you take more informed decisions.
NEOPHARM CO., LTD. dividend yield was 2.90% in 2023, and payout ratio reached 25.27%. The year before the numbers were 3.65% and 32.15% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Nov 24, 2024, the company has 153.00 employees. See our rating of the largest employees — is NEOPHARM CO., LTD. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. NEOPHARM CO., LTD. EBITDA is ‪27.63 B‬ KRW, and current EBITDA margin is 27.73%. See more stats in NEOPHARM CO., LTD. financial statements.
Like other stocks, 092730 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade NEOPHARM CO., LTD. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So NEOPHARM CO., LTD. technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating NEOPHARM CO., LTD. stock shows the sell signal. See more of NEOPHARM CO., LTD. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.